D. Royer

发表

Vaccine-induced Antibodies Target Sequestered Viral Antigens to Prevent Ocular HSV-1 Pathogenesis, Preserve Vision, and Preempt Productive Neuronal Infection

D. Robertson, D. Carr, D. Royer, 2019, Mucosal Immunology.

Mucosal Regulatory System for Balanced Ocular Immunity

D. Carr, D. Royer, Micaela L. Montgomery, 2020 .

Complement and CD4+ T cells drive context-specific corneal sensory neuropathy

D. Saban, V. Perez, R. Mathew, 2019, eLife.

The Neonatal Fc Receptor and Complement Fixation Facilitate Prophylactic Vaccine-Mediated Humoral Protection against Viral Infection in the Ocular Mucosa

W. Halford, D. Carr, D. Royer, 2017, The Journal of Immunology.

Reply to “Highly Efficacious Novel Vaccine, Humoral Immunity, and Ocular Herpes Simplex Virus 1: Reality or Myth?”

D. Carr, D. Royer, Derek J. Royer, 2017, Journal of Virology.

Impact of Type I Interferon on the Safety and Immunogenicity of an Experimental Live-Attenuated Herpes Simplex Virus 1 Vaccine in Mice

W. Halford, D. Carr, D. Royer, 2017, Journal of Virology.

Granulocytes in Ocular HSV-1 Infection: Opposing Roles of Mast Cells and Neutrophils.

Christopher D. Conrady, D. Carr, D. Royer, 2015, Investigative ophthalmology & visual science.

Regulation of Immune Responses by Nonhematopoietic Cells in Asthma

D. Cook, D. Royer, Derek J. Royer, 2021, The Journal of Immunology.

Tripartite-Motif 21 (TRIM21) Deficiency Results in a Modest Loss of Herpes Simplex Virus (HSV)-1 Surveillance in the Trigeminal Ganglia Following Cornea Infection

D. Carr, D. Royer, G. Gmyrek, 2022, Viruses.

and Encephalitis Driven Brain Lateral Ventricle Enlargement - Pathway Are Required To Counter HSV-1 Microglia and a Functional Type I IFN

N. Rooijen, A. Alleman, Christopher D. Conrady, 2013 .

The current state of vaccine development for ocular HSV-1 infection

D. Carr, D. Royer, A. Cohen, 2015, Expert review of ophthalmology.

Corneal Epithelial Cells Exhibit Myeloid Characteristics and Present Antigen via MHC Class II

Y. Le, M. Elliott, D. Carr, 2018, Investigative ophthalmology & visual science.

A Highly Efficacious Herpes Simplex Virus 1 Vaccine Blocks Viral Pathogenesis and Prevents Corneal Immunopathology via Humoral Immunity

W. Halford, D. Carr, D. Royer, 2016, Journal of Virology.

Herpes Simplex Virus 1 (HSV-1) 0ΔNLS Live-Attenuated Vaccine Protects against Ocular HSV-1 Infection in the Absence of Neutralizing Antibody in HSV-1 gB T Cell Receptor-Specific Transgenic Mice

D. Carr, D. Royer, A. Filiberti, 2020, Journal of Virology.

Thrombocytopenia as an adverse effect of complementary and alternative medicines, herbal remedies, nutritional supplements, foods, and beverages *

J. George, D. Royer, Deirdra R. Terrell, 2010, European journal of haematology.

Profiling antibodies to class II HLA in transplant patient sera.

Curtis McMurtrey, Wilfried Bardet, W. Hildebrand, 2014, Human immunology.

Microglia and a Functional Type I IFN Pathway Are Required To Counter HSV-1–Driven Brain Lateral Ventricle Enlargement and Encephalitis

N. Van Rooijen, A. Alleman, Christopher D. Conrady, 2013, The Journal of Immunology.

A STING-dependent innate-sensing pathway mediates resistance to corneal HSV-1 infection via upregulation of the antiviral effector tetherin

D. Carr, D. Royer, Derek J. Royer, 2015, Mucosal Immunology.

Herpesvirus-Associated Lymphadenitis Distorts Fibroblastic Reticular Cell Microarchitecture and Attenuates CD8 T Cell Responses to Neurotropic Infection in Mice Lacking the STING-IFNα/β Defense Pathways

Christopher D. Conrady, D. Carr, D. Royer, 2016, The Journal of Immunology.

A neutrophil/TGF-β axis limits the pathogenicity of allergen-specific CD4+ T cells

D. Cook, Seddon Y. Thomas, G. Whitehead, 2022, JCI insight.

An intact complement system dampens cornea inflammation during acute primary HSV-1 infection

D. Carr, D. Royer, A. Filiberti, 2021, Scientific Reports.